vs
アレジオン（ALLE）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.0B、アレジオンの約1.5倍）。アレジオンの純利益率が高く（13.4% vs 9.5%、差は3.9%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 9.7%）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 3.5%）
アレジオン（Allegion plc）は世界中で機械式・電子式セキュリティ製品およびソリューションを製造販売している。取扱製品はドアクローザー、出入り口制御装置、錠前、電子入退室管理システム、勤怠管理システム、ドアシステムや各種付属部品など多岐にわたり、商業施設、公共施設、住宅などの顧客に提供している
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ALLE vs EHC — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.0B | $1.5B |
| 純利益 | $138.1M | $146.1M |
| 粗利率 | 44.0% | — |
| 営業利益率 | 18.9% | 16.7% |
| 純利益率 | 13.4% | 9.5% |
| 売上前年比 | 9.7% | 9.9% |
| 純利益前年比 | -6.8% | 20.8% |
| EPS（希薄化後） | — | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $941.9M | $1.5B | ||
| Q4 24 | $945.6M | $1.4B | ||
| Q3 24 | $967.1M | $1.4B | ||
| Q2 24 | $965.6M | $1.3B |
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $146.1M | ||
| Q3 25 | $188.4M | $126.5M | ||
| Q2 25 | $159.7M | $142.1M | ||
| Q1 25 | $148.2M | $151.5M | ||
| Q4 24 | $144.1M | $120.9M | ||
| Q3 24 | $174.2M | $108.2M | ||
| Q2 24 | $155.4M | $114.1M |
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | — | ||
| Q3 25 | 45.8% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 44.9% | — | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 44.4% | — |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 16.7% | ||
| Q3 25 | 21.8% | 14.9% | ||
| Q2 25 | 21.5% | 16.2% | ||
| Q1 25 | 20.9% | 16.4% | ||
| Q4 24 | 19.5% | 14.3% | ||
| Q3 24 | 22.2% | 13.6% | ||
| Q2 24 | 21.6% | 14.3% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 9.5% | ||
| Q3 25 | 17.6% | 8.6% | ||
| Q2 25 | 15.6% | 9.7% | ||
| Q1 25 | 15.7% | 10.4% | ||
| Q4 24 | 15.2% | 8.6% | ||
| Q3 24 | 18.0% | 8.0% | ||
| Q2 24 | 16.1% | 8.8% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $1.43 | ||
| Q3 25 | $2.18 | $1.24 | ||
| Q2 25 | $1.85 | $1.39 | ||
| Q1 25 | $1.71 | $1.48 | ||
| Q4 24 | $1.65 | $1.18 | ||
| Q3 24 | $1.99 | $1.06 | ||
| Q2 24 | $1.77 | $1.12 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $308.9M | $72.2M |
| 総負債低いほど良い | $2.0B | $2.4B |
| 株主資本純資産 | $2.1B | $2.4B |
| 総資産 | $5.3B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.97× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $72.2M | ||
| Q3 25 | $302.7M | $48.7M | ||
| Q2 25 | $656.8M | $99.1M | ||
| Q1 25 | $494.5M | $95.8M | ||
| Q4 24 | $503.8M | $85.4M | ||
| Q3 24 | $878.9M | $147.8M | ||
| Q2 24 | $747.5M | $154.4M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.4B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.1B | $2.3B | ||
| Q1 25 | $2.0B | $2.3B | ||
| Q4 24 | $2.0B | $2.4B | ||
| Q3 24 | $2.4B | $2.3B | ||
| Q2 24 | $2.4B | $2.7B |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $2.4B | ||
| Q3 25 | $1.9B | $2.4B | ||
| Q2 25 | $1.8B | $2.3B | ||
| Q1 25 | $1.6B | $2.2B | ||
| Q4 24 | $1.5B | $2.1B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.4B | $1.8B |
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $7.1B | ||
| Q3 25 | $5.2B | $6.9B | ||
| Q2 25 | $4.9B | $6.8B | ||
| Q1 25 | $4.6B | $6.6B | ||
| Q4 24 | $4.5B | $6.5B | ||
| Q3 24 | $5.0B | $6.5B | ||
| Q2 24 | $4.8B | $6.4B |
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 1.00× | ||
| Q3 25 | 1.07× | 1.01× | ||
| Q2 25 | 1.16× | 1.02× | ||
| Q1 25 | 1.24× | 1.08× | ||
| Q4 24 | 1.33× | 1.14× | ||
| Q3 24 | 1.53× | 1.20× | ||
| Q2 24 | 1.69× | 1.46× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $101.3M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $116.7M |
| FCFマージンFCF / 売上 | — | 7.6% |
| 設備投資強度設備投資 / 売上 | 2.0% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 0.73× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | — | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $346.0M | ||
| Q3 25 | $229.5M | $270.8M | ||
| Q2 25 | $209.7M | $270.2M | ||
| Q1 25 | $104.5M | $288.6M | ||
| Q4 24 | $219.0M | $278.8M | ||
| Q3 24 | $231.9M | $267.8M | ||
| Q2 24 | $173.0M | $217.4M |
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $116.7M | ||
| Q3 25 | $209.8M | $83.7M | ||
| Q2 25 | $192.0M | $113.3M | ||
| Q1 25 | $83.4M | $125.5M | ||
| Q4 24 | $194.9M | $80.1M | ||
| Q3 24 | $212.0M | $120.3M | ||
| Q2 24 | $152.1M | $60.5M |
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 7.6% | ||
| Q3 25 | 19.6% | 5.7% | ||
| Q2 25 | 18.8% | 7.8% | ||
| Q1 25 | 8.9% | 8.6% | ||
| Q4 24 | 20.6% | 5.7% | ||
| Q3 24 | 21.9% | 8.9% | ||
| Q2 24 | 15.8% | 4.6% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 14.8% | ||
| Q3 25 | 1.8% | 12.7% | ||
| Q2 25 | 1.7% | 10.8% | ||
| Q1 25 | 2.2% | 11.2% | ||
| Q4 24 | 2.5% | 14.1% | ||
| Q3 24 | 2.1% | 10.9% | ||
| Q2 24 | 2.2% | 12.1% |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 2.37× | ||
| Q3 25 | 1.22× | 2.14× | ||
| Q2 25 | 1.31× | 1.90× | ||
| Q1 25 | 0.71× | 1.90× | ||
| Q4 24 | 1.52× | 2.31× | ||
| Q3 24 | 1.33× | 2.48× | ||
| Q2 24 | 1.11× | 1.91× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
